Desco Infratech IPO allotment date today: Desco Infratech IPO share allotment will be finalised today (Thursday, March 27). (https://descoinfra.co.in/) Desco Infratech IPO allotment date today ...

Active Infrastructures IPO allotment date is today, March 26.(https://activeinfra.in/) Active Infrastructures IPO allotment date today: Active Infrastructures IPO ...

Identixweb IPO allotment will be finalized today. Investors can check their status on Skyline Financial Services' website.

Step 5: Click 'submit'. The status of your Desco Infratech IPO allotment will appear on the screen. Step 2: Select the company's name "Desco Infratech IPO" from the drop-down. Step 3: Click on ...

Active Infrastructures IPO allotment will be finalised today. Investors can check their allotment status on Bigshare Services ...

The company will finalise the IPO share allotment by April 1. The trading in its equity shares will commence on the BSE SME effective April 3, as per the schedule published in the prospectus.

Grand Continent Hotels will finalise the IPO share allotment by March 25, while the trading in its equity shares will commence on the NSE Emerge, effective March 27. The company that operates in ...

ATC Energies System’s SME IPO is valued at Rs 63.76 crore and includes a fresh issue of 4.32 million equity shares along with an offer for sale (OFS), where promoter Sandeep Gangabishan Bajoria is ...

On March 3, 2025, Glenmark Pharmaceuticals announced that it has acquired Acetylcysteine Injection for sale in the United States. As part of the expansion move into US injectable drug market ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% OTC, which is the generic of Alcon’s Pataday Once Daily Relief ...

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...